|

Anxiety Clinical Trials in Long Beach, CA

42 recruiting studies within 50 miles

Phase
Trial Phase Dist.
P3b Short-term Study of CTN in Patients With ADHD and Comorbid AnxietyPhase 3<1 mi
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety DisorderPhase 2<1 mi
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)Phase 39 mi
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)Phase 310 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)Phase 215 mi
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety DisorderPhase 319 mi
Exparel vs. ACB With Bupivacaine for ACL ReconstructionPhase 120 mi
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age20 mi
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety DisorderPhase 220 mi
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety DisorderPhase 220 mi
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac DiagnosisN/A20 mi
Sensory Adapted Dental Environments to Enhance Oral Care for Children With and Without Dental Fear and AnxietyN/A20 mi
Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)N/A20 mi
Music-Based Interventions, Aging, Alzheimer's DiseaseN/A20 mi
Unconscious Reduction of Fear Through Decoded Neuro-ReinforcementN/A20 mi
Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age YouthN/A20 mi
Reward Processing and Exposure Therapy for Social Anxiety DisorderN/A20 mi
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic CancerEarly 120 mi
Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic ProceduresN/A20 mi
S.T.A.N.D. Alacrity Center Signature ProjectN/A20 mi
The Role of Virtual Reality During Regional AnesthesiaN/A20 mi
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant WomenPhase 2/320 mi
Virtual Reality (VR) for Interventional Radiology (IR) Procedures20 mi
Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast BiopsiesN/A20 mi
Social Support and Reduced Fear AcquisitionN/A20 mi
Social Support and Enhanced Fear ExtinctionN/A20 mi
Project 2: Optimizing Engagement and Outcomes in STAND Digital TherapyN/A20 mi
VR AI Meditation for PainN/A20 mi
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive DisorderN/A20 mi
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in ChildrenN/A20 mi
Intracranial Neurophysiological Signatures of Fear and Anxiety in HumansN/A20 mi
A Study of NTX-1472 in Social Anxiety DisorderPhase 220 mi
RCT for Latina Mental Health Using Web-Based AppsN/A20 mi
Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With CancerN/A22 mi
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory SettingN/A22 mi
Personalized Brain Stimulation to Treat Chronic Concussive SymptomsPhase 224 mi
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)Phase 324 mi
Filipino Family Health Initiative 1.0N/A26 mi
Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and CaregiversN/A28 mi
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety DisorderPhase 230 mi
Mindful Self-Compassion to Address PTSD and Substance Use in Unhoused WomenN/A32 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 236 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.